Asset Details
Do you wish to reserve the book?
Short term oral minocycline treatment of meibomianitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Short term oral minocycline treatment of meibomianitis
Do you wish to request the book?
Short term oral minocycline treatment of meibomianitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Short term oral minocycline treatment of meibomianitis
2006
Overview
Aim: To evaluate the clinical impact, aqueous tear parameters, and meibomian gland morphology in patients with primary meibomianitis before, during, and 3 months after a course of oral minocycline. Methods: 16 patients were prospectively enrolled, 11 male and five female (mean age 69 years old). Each patient received routine clinical evaluations before, after 3 months therapy, and at 6 month study follow up visit. The clinical appearance, tear volume, flow and turnover, evaporation, Schirmer I test, meibomian gland dropout, lissamine green staining, and bacteriology wer evaluated. Results: Improvement was observed in clinical signs of meibomianitis at the second and third visits. Microbial culture findings improved. Decreased aqueous tear volume and flow, and increased evaporation rate range at 35–45% relative humidity (RH) (p<0.05) were also detected. Other related tear parameters did not change. Meibomian gland dropout showed no improvement. Conclusions: 3 months of oral minocycline resulted in clinical improvements in all meibomianitis signs that persisted for at least 3 months after discontinuation despite decreased aqueous tear volume and flow with increased evaporation (35–45% RH). However, there was improvement in the turbidity of secretions. Short term minocycline therapy probably has efficacy in the management of meibomianitis that extends beyond eradication of bacteria.
Publisher
BMJ Publishing Group Ltd,BMJ,BMJ Publishing Group LTD,BMJ Group
Subject
/ Aged
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - therapeutic use
/ Biological and medical sciences
/ Clinical Science - Extended Report
/ dry eye
/ Dry Eye Syndromes - drug therapy
/ Dry Eye Syndromes - microbiology
/ Dry Eye Syndromes - pathology
/ Eyelid Diseases - drug therapy
/ Eyelid Diseases - microbiology
/ Female
/ Humans
/ Male
/ Meibomian Glands - microbiology
/ Meibomian Glands - pathology
/ Minocycline - administration & dosage
/ Minocycline - therapeutic use
/ Patients
/ Staphylococcal Infections - drug therapy
/ Studies
